<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01352052</url>
  </required_header>
  <id_info>
    <org_study_id>BDS-2011-099</org_study_id>
    <nct_id>NCT01352052</nct_id>
  </id_info>
  <brief_title>Interdisciplinary Rehabilitation of Patients With Chronic Widespread Pain</brief_title>
  <acronym>IMPROvE</acronym>
  <official_title>Interdisciplinary Rehabilitation and Evaluation Programme for Patients With Chronic Widespread Pain: Randomized Controlled Trial, the IMPROvE Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Frederiksberg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oak Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Frederiksberg University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the current study is to evaluate the outcome of an interdisciplinary
      multi-component rehabilitation programme customized to patients with chronic widespread pain
      (CWP) based on multidimensional diagnostic assessment including sub-grouping, and aiming to
      improve functional ability in everyday life. The hypothesis is that a patient-focused
      multi-disciplinary rehabilitation approach will improve both functional ability and quality
      of life for patients with CWP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic widespread pain (CWP) is common in the general population and represents a major
      clinical challenge due to the complexity of the disorder. Apart from pain, CWP comprises a
      range of secondary features including non-restorative sleep, fatigue, cognitive dysfunction,
      emotionally distress and disability affecting daily life activities and health-related
      quality of life. CWP is strongly associated with incapacity for normal employment and poor
      social participation, and incurs high direct medical costs as well as significant indirect
      costs, e.g. sick-leave and disability compensation.

      Currently there are no official recommendations concerning the diagnosing and management of
      patients suffering from CWP in the European health care system. The complexity of the
      condition underlines the necessity of a comprehensive multi-dimensional assessment and a
      patient-focused multi-component intervention.

      The present study is a prospective, pragmatic randomized controlled trial (RCT), with blinded
      outcome assessors, aiming to evaluate the outcome of an interdisciplinary multi-component
      rehabilitation programme customized to patients with CWP and focusing on functional ability
      and adaptations in everyday life. 176 patients with CWP recruited from the department of
      rheumatology at Frederiksberg Hospital will be consecutively enrolled in the study over a
      1-year period. Participants will be randomized to a 2-weeks non-residential, group-based,
      multi-component treatment course conducted by an interdisciplinary team or 6-months waiting
      list for the same course.

      The instrumentation for intervention planning, as well as for outcome evaluation, will be
      based on an ICF measurement framework, as recommended by WHO and performance-based assessment
      of functional ability (AMPS) and self-reported, health-related quality of life (SF-36) will
      be applied as primary outcome measures.

      Overall, the study results is expected to contribute to the development of more
      cost-effective health care strategies aiming at prevention of mal-adaptive illness behaviour
      and progressive functional loss in patients suffering from CWP.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of Motor and Process Skills (AMPS)</measure>
    <time_frame>change from baseline at the end of intervention and 6 months follow-up</time_frame>
    <description>The Assessment of Motor and Process Skills (AMPS) is a performance-based evaluation of ADL ability, developed to establish the extent of an individual's ability to perform and complete daily life tasks independently and in a safe and efficient manner. Further, the AMPS measurement model incorporates the use of Rasch analysis, and therefore provides equal-interval linear measures of the quality of ADL task performances. Two separate measures are reported, one for ADL motor ability (moving self and objects) and one for ADL process ability (organising and adapting actions).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SF-36 Mental Composite Score</measure>
    <time_frame>change from baseline at the end of intervention and 6 months follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life scales; Short-Form-36 Health Survey (SF-36)</measure>
    <time_frame>change from baseline at the end of intervention and 6 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease severity scales;Fibromyalgia Impact Questionnaire (FIQ)</measure>
    <time_frame>change from baseline at the end of intervention and 6 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety; Generalised Anxiety Disorder (GAD-10)</measure>
    <time_frame>change from baseline at the end of intervention and 6 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression; Major Depression Inventory (MDI)</measure>
    <time_frame>change from baseline at the end of intervention and 6 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain catastrophizing; Coping Strategy Questionnaire (CSQ)</measure>
    <time_frame>change from baseline at the end of intervention and at 6 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain self-efficacy; Pain Self-Efficacy Questionnaire</measure>
    <time_frame>change from baseline at the end of treatment and at 6 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive functioning; ISPOCD 2 test battery</measure>
    <time_frame>change from baseline at the end of intervention and 6 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity intolerance; The Measure of Functional Ability (Tiredness)</measure>
    <time_frame>change from baseline at the end of intervention and 6 months follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">192</enrollment>
  <condition>Chronic Widespread Pain</condition>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>waiting list assignment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>6 months waiting list assignment followed by the 2-week interdisciplinary rehabilitation programme</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention: interdisciplinary rehabilitation programme</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A two-weeks non-residential, group-based, psycho-educative treatment course conducted by an interdisciplinary team.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>interdisciplinary rehabilitation</intervention_name>
    <description>A two-weeks non-residential, group-based, psycho-educative, multi-component treatment course conducted by an interdisciplinary team consisting of a rheumatologist, a nurse, occupational therapists, physical therapists, and a psychologist. The rehabilitation Programme comprises of a combination of lectures and group discussions, as well as instructions during physical exercise and task performance. The main focus is on education and adaptations in everyday life. There is a scheduled Programme for every day, with a daily time schedule between four and six hours. There will be a maximum of eight participants in each group.</description>
    <arm_group_label>Intervention: interdisciplinary rehabilitation programme</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age above 18

          -  fulfills the American College of Rheumatology (ACR) 1990 classification criteria of
             widespread musculoskeletal pain i.e. reporting of pain axially and in all 4 body
             quadrants for a minimum duration of 3 months

          -  willing to participate in a 2-week group-based rehabilitation programme

        Exclusion Criteria:

          -  severe physical impairment necessitating assistance in personal activities of daily
             living

          -  concurrent history of major psychiatric disorder not related to the pain disorder

          -  other medical conditions capable of causing patients symptoms (e.g. uncontrolled
             inflammatory/autoimmune disorder, uncontrolled endocrine disorder, malignancy)

          -  not Danish speaking

          -  enrollment in any other clinical trial within the last 30 days
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bente Danneskiold-Sams√∏e, Professor</last_name>
    <role>Study Director</role>
    <affiliation>The Parker Institute, Frederiksberg University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kirstine Amris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Parker Institute, Frederiksberg University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Parker Institute, Frederiksberg Hospital</name>
      <address>
        <city>Frederiksberg</city>
        <zip>2000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Parker Institute, Frederiksberg University Hospital</name>
      <address>
        <city>Frederiksberg</city>
        <zip>2000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.frederiksberghospital.dk/parker</url>
    <description>Web page of the Parker Institute, Frederiksberg University Hospital, Denmark</description>
  </link>
  <reference>
    <citation>Amris K, Jespersen A, Bliddal H. Self-reported somatosensory symptoms of neuropathic pain in fibromyalgia and chronic widespread pain correlate with tender point count and pressure-pain thresholds. Pain. 2010 Dec;151(3):664-9. doi: 10.1016/j.pain.2010.08.023. Epub 2010 Sep 15.</citation>
    <PMID>20832941</PMID>
  </reference>
  <reference>
    <citation>Waehrens EE, Amris K, Fisher AG. Performance-based assessment of activities of daily living (ADL) ability among women with chronic widespread pain. Pain. 2010 Sep;150(3):535-41. doi: 10.1016/j.pain.2010.06.008. Epub 2010 Jul 3.</citation>
    <PMID>20598803</PMID>
  </reference>
  <reference>
    <citation>Jespersen A, Dreyer L, Kendall S, Graven-Nielsen T, Arendt-Nielsen L, Bliddal H, Danneskiold-Samsoe B. Computerized cuff pressure algometry: A new method to assess deep-tissue hypersensitivity in fibromyalgia. Pain. 2007 Sep;131(1-2):57-62. Epub 2007 Jan 25.</citation>
    <PMID>17257757</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2011</study_first_submitted>
  <study_first_submitted_qc>May 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2011</study_first_posted>
  <last_update_submitted>August 9, 2016</last_update_submitted>
  <last_update_submitted_qc>August 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Frederiksberg University Hospital</investigator_affiliation>
    <investigator_full_name>Henning Bliddal</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>chronic widespread pain</keyword>
  <keyword>fibromyalgia</keyword>
  <keyword>outcome assessment</keyword>
  <keyword>functional ability</keyword>
  <keyword>AMPS</keyword>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

